← Main Index Directory
Pinealon Assay Protocol
In-Vitro ArchitectureDelivery & Half-Life Parameters
Validated Mapping Vector: Oral capsules or subcutaneous delivery methods show high functionality.
Biological Half-Life Metric: Enjoys extreme intracellular stability due to its ultra-short peptide structure.
Recommended In-Vitro Dosing Architecture
Oral protocol vectors measure 10mg to 20mg per day. Subcutaneous trials log 1mg to 2mg daily.
Standard Target Observation Timelines
Administered via short 20 to 30-day tracking pulses, repeated every 6 months to evaluate cell health over time.